A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China

Volume: 226, Issue: 2, Pages: 251.e1 - 251.e12
Published: Feb 1, 2022
Abstract
Low-dose aspirin has been the most widely studied preventive drug for preeclampsia. However, guidelines differ considerably from country to country regarding the prophylactic use of aspirin for preeclampsia. There is limited evidence from large trials to determine the effect of 100 mg of aspirin for preeclampsia screening in women with high-risk pregnancies, based on maternal risk factors, and to guide the use of low-dose aspirin in preeclampsia...
Paper Details
Title
A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China
Published Date
Feb 1, 2022
Volume
226
Issue
2
Pages
251.e1 - 251.e12
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.